SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-21-331204
Filing Date
2021-11-16
Accepted
2021-11-16 16:07:01
Documents
2
Group Members
BLACKSTONE CLARUS GP L.L.C.BLACKSTONE GROUP MANAGEMENT L.L.C.BLACKSTONE HOLDINGS I L.P.BLACKSTONE HOLDINGS I/II GP L.L.CBLACKSTONE LIFE SCIENCES ASSOCIATES V (CYM) L.L.C.BXLS V - AUTOBAHN L.P.STEPHEN A. SCHWARZMAN

Document Format Files

Seq Description Document Type Size
1 SC 13D d628355dsc13d.htm SC 13D 173003
2 EXHIBIT A d628355dex99a.htm EX-99.A 11514
  Complete submission text file 0001193125-21-331204.txt   186681
Mailing Address 345 PARK AVENUE NEW YORK NY 10154
Business Address 345 PARK AVENUE NEW YORK NY 10154 (212) 583-5000
Blackstone Inc (Filed by) CIK: 0001393818 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 6282 Investment Advice

Mailing Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP
Business Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP 44 20 3829 6230
Autolus Therapeutics plc (Subject) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90550 | Film No.: 211416097
SIC: 2836 Biological Products, (No Diagnostic Substances)